Scarica l'app Stockscreener
12.18
0.67%
0.38
Benitec Biopharma Inc Borsa (BNTC) Ultime notizie
Institutional investors are Benitec Biopharma Inc.'s (NASDAQ:BNTC) biggest bettors and were rewarded after last week's US$33m market cap gain - Simply Wall St
Benitec Biopharma (NASDAQ:BNTC) Share Price Crosses Above 50-Day Moving AverageTime to Sell? - MarketBeat
Benitec Biopharma (BNTC) to Release Earnings on Monday - MarketBeat
(BNTC) Technical Pivots with Risk Controls - Stock Traders Daily
Franklin Resources Inc. Acquires Significant Stake in Benitec Bi - GuruFocus.com
Benitec Biopharma to Participate in Upcoming Conferences in January and February - GlobeNewswire
BNTCBenitec Biopharma Inc. Latest Stock News & Market Updates - StockTitan
Benitec Biopharma Announces Three Major Conference Presentations for Early 2025 - StockTitan
Guggenheim Initiates Coverage of Benitec Biopharma (BNTC) with Buy Recommendation - MSN
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Average Rating of “Buy” by Brokerages - Defense World
Benitec Biopharma: Early Positive Data, Small Target Market, Little Competition - Seeking Alpha
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update - MarketBeat
Why You Shouldn't Bet Against Benitec Biopharma (BNTC) Stock - MSN
Benitec Biopharma Inc. (NASDAQ:BNTC) Shares Purchased by Geode Capital Management LLC - Defense World
Benitec Biopharma (NASDAQ:BNTC) Stock Crosses Below 50 Day Moving AverageTime to Sell? - MarketBeat
(BNTC) Proactive Strategies - Stock Traders Daily
Top 5 Small-cap Biotech Stocks (Updated January 2025) - Investing News Network
Brokerages Set Benitec Biopharma Inc. (NASDAQ:BNTC) Price Target at $24.43 - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Rating of “Buy” from Analysts - Defense World
How To Trade (BNTC) - Stock Traders Daily
Benitec Biopharma Inc. (NASDAQ:BNTC) Director Buys $301,971.96 in Stock - MarketBeat
Suvretta capital management buys $527,174 in Benitec Biopharma stock - Investing.com
Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why - Yahoo Finance
Equities Analysts Issue Forecasts for BNTC Q2 Earnings - Defense World
Q2 Earnings Estimate for BNTC Issued By HC Wainwright - MarketBeat
Where are the Opportunities in (BNTC) - Stock Traders Daily
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) - Yahoo Finance
Benitec Biopharma stock soars to 52-week high of $13.29 By Investing.com - Investing.com South Africa
Benitec Biopharma stock soars to 52-week high of $13.29 - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Now Covered by HC Wainwright - Defense World
Benitec Biopharma initiated with a Buy at H.C. Wainwright - Yahoo Finance
Benitec Biopharma's SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Benitec Biopharma announces executive team changes - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Benitec Biopharma announces executive team changes By Investing.com - Investing.com Australia
Benitec Biopharma (NASDAQ:BNTC) Appoints New Chief Operating Officer and Makes Changes to Executive Officers’ Roles and Compensation - Defense World
Short Interest in Benitec Biopharma Inc. (NASDAQ:BNTC) Grows By 6.9% - MarketBeat
Robert W. Baird Begins Coverage on Benitec Biopharma (NASDAQ:BNTC) - Defense World
Benitec Biopharma Shakes Up Management Team - MarketWatch
Baird Initiates Coverage of Benitec Biopharma (BNTC) with Outperform Recommendation - MSN
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated at Robert W. Baird - MarketBeat
Baird sets $30 target on Benitec BioPharma, cites gene therapy By Investing.com - Investing.com UK
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
Benitec Biopharma approves preferred stock issuance By Investing.com - Investing.com Canada
Benitec Biopharma approves preferred stock issuance - Investing.com
Benitec Biopharma stock soars to 52-week high of $12.95 By Investing.com - Investing.com Canada
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
When (BNTC) Moves Investors should Listen - Stock Traders Daily
Benitec Biopharma shareholders approve key proposals By Investing.com - Investing.com Canada
4.75%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):